View Author
scopus: 7006135531

Bosch, J.M. van den

(Jules van den Bosch)


patient pneumoniae rdna lps elisa sarcoidosi infection chlamydia pneumoniae infection elisa result assay ratio cd 4+/cd ratio mif assay antibody 15-3 disease 4+/cd cancer muc 1 568 sensitivity breast diagnosis value group 15-3 levels serum sarcoidosis patients table chlamydia pneumoniae level /g polymorphism specificity cd 103+cd ratio breast cancer study sample cd 103 culture lymphocytes bal fluid breast cancer patients lung diseases cd 4+ t-lymphocytes antonius hospital polymorphism specimen titer women blood hospital netherland criteria marker serum sample pneumonia tumor chlamydial 100.0 fluid l öfgren syndrome genotype cf test cd 103 expression microbiol 103+cd prevalence mif test expression cd 4+ alveolitis t-lymphocyte chlamydia pneumoniae infection serum samples control pneumoniae infections antigen alveoliti chlamydial infection lavage bronchoalveolar analysis




4 Most Recent Publications

Lapatinib: Clinical benefit in patients with HER2-positive advanced breast cancer (Article)
Kroep, J.R. Linn, S. Vermeulen, G.J. Hop, W.C.J. Nortier, J.W. Boven, E. Bloemendal, H.J. Baas, J. Mandjes, I.A.M. Bosch, J.M. van den Smit, W. Graaff, H.J. de Schröder, C.P.
2010-01-01
Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis (Article)
Heron, M. Slieker, W.A.T. Zanen, P. Lochem, E.G. van Hooijkaas, H. Bosch, J.M. van den Velzen-Blad, H. van
2008-03-01
MUC1 568 A/G genotype-dependent Cancer Antigen 15-3 levels in breast cancer patients (Article)
Kruit, A. Tilanus-Linthorst, M.M.A. Boonstra, J.G. Schaik, R.H.N. van Grutters, J.C. Bosch, J.M. van den Ruven, H.J.T.
2008-01-01
Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections (Article)
Verkooyen, R.P.A.J. Willemse, D. Hiep-van Casteren, S.C. Joulandan, S.A. Snijder, R.J. Helden, H.P. van Peeters, M.F. Verbrugh, H.A. Bosch, J.M. van den
1998-01-01